SCHEMBL3971707

SCHEMBL3971707

O=Cc1cccc(S(=O)(=O)c2ccc(F)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 10/20 0.50
HTR2C P28335 7/20 0.50
KCNH2 Q12809 6/20 0.50
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
HTR2B P41595 2/20 0.43
CYP2D6 P10635 1/20 0.42
NFE2L2 Q16236 1/20 0.42
NAMPT P43490 2/20 0.41
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29571855 1.00 HTR2A (0.50) HTR2AHTR2CKCNH2MAOAMAOB
SCHEMBL6853554 0.87 CA12 (0.49) HTR2AHTR2CKCNH2CA12CA1
SCHEMBL6853269 0.87 ALDH1A1 (0.50) CA12CA1CA2CA9LMNA
SCHEMBL31604493 0.87 ALDH1A1 (0.50) CA12CA1CA2CA9LMNA
SCHEMBL2538638 0.85 HTR6 (0.56) HTR2AHTR2CKCNH2MAOAMAOB
SCHEMBL3259912 0.83 HTR2A (0.78) HTR2AHTR2CKCNH2NFE2L2
SCHEMBL3259916 0.83 HTR2A (0.78) HTR2AHTR2CKCNH2NFE2L2
SCHEMBL5122472 0.83 HTR2A (0.51) HTR2AHTR2CKCNH2HTR2BLMNA
SCHEMBL2536086 0.83 GAA (0.55) MAOAMAOBCA12CA1CA2
SCHEMBL3600328 0.83 ALDH1A1 (0.55) CA12CA1CA2CA9NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110835335-B 2, 5-diketopiperazine compound and application thereof in preparation of anti-cancer drugs 深圳华大海洋科技有限公司 2022-04-15 CN disclosed
CN-110835335-A 2, 5-diketopiperazine compound and application thereof in preparation of anti-cancer drugs 青岛海洋生物医药研究院股份有限公司 2020-02-25 CN disclosed
WO-2009044147-A1 INDOLIZINE DERIVATIVES WITH CRTH2 RECEPTOR AFFINITY FOR THE TREATMENT OF INFLAMMATORY DISEASES ARGENTA DISCOVERY LIMITED (GB) 2009-04-09 WO disclosed